Therapeutic Goods Information (Approvals relating to Medicine Shortages) Specification 2017 (Cth)

Therapeutic Goods Information (Approvals relating to Medicine Shortages) Specification 2017 Therapeutic Goods Act 1989

I, LARRY KELLY, a delegate of the Minister for Health, make this specification under subsection 61(5D) of the Therapeutic Goods Act 1989.

Dated 15 December 2017

(Signed by)

LARRY KELLY

Delegate of the Minister for Health

1 Name of specification This specification is the Therapeutic Goods Information (Approvals relating to Medicine Shortages) Specification 2017. 2 Commencement (1) Each provision of this specification specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information Column 1 Column 2 Column 3 Provisions Commencement Date/Details 1. The whole of this specification The day after this specification is registered. 19 December 2017

Note: This table relates only to the provisions of this specification as originally made. It will not be amended to deal with any later amendments of this specification. (2) Any information in column 3 of the table is not part of this specification. Information may be inserted in this column, or information in it may be edited, in any published version of this specification. 3 Authority This specification is made under subsection 61(5D) of the Therapeutic Goods Act 1989. 4 Definitions In this specification: Act means the Therapeutic Goods Act 1989. active ingredient has the meaning as in section 2 of the Therapeutic Goods Regulations 1990.

Note A number of expressions used in this specification are defined in the Act, including the following: (a) included in the Register; (b) indications; (c) Register; (d) registered goods; (e) registration number; (f) sponsor; (g) therapeutic goods;